Search | WHO COVID-19 Research Database

Senior, Melanie.

Nat Biotechnol ; 38(7): 798-805, 2020 07.

Article in English | MEDLINE | ID: covidwho-1241981

Subject(s)

Biological Products/economics , Capital Financing/economics , Drug Industry/economics , Economics, Hospital , Delivery of Health Care/economics , Humans

Biotech bubbles during the global recession.

Senior, Melanie.

Nat Biotechnol ; 39(4): 408-413, 2021 04.

Article in English | MEDLINE | ID: covidwho-1213933

Europe's biotech renaissance.

Senior, Melanie.

Nat Biotechnol ; 38(4): 408-415, 2020 04.

Article in English | MEDLINE | ID: covidwho-831238

Subject(s)

Biotechnology/economics , Biotechnology/trends , Drug Industry/economics , Drug Industry/trends , Europe , Humans , Investments/economics , Investments/trends

Biotech companies prepare for COVID-19 downturn

Senior, Melanie.

Non-conventional | WHO COVID | ID: covidwho-261143

ABSTRACT

Biopharmaceutical companies are awash with more cash than at any time in the sector’s history. But they are scrambling to prepare for the drought of a COVID-19-related recession.

Subject(s)

Subject(s)

ABSTRACT

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL